◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Kane Biotech Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 8,499 27,997 412,513 125,858 1.3M --
Operating Revenue 8,499 27,997 412,513 125,858 1.3M --
Cost Of Revenue 13,627 73,523 370,066 213,063 723,944 --
Gross Profit -5,128 -45,526 42,447 -87,205 558,754 --
Selling General And Administration 378,668 139,703 942,486 325,957 986,824 --
General And Administrative Expense 378,668 139,703 942,486 325,957 986,824 --
Research And Development 159,638 90,227 261,019 607,521 183,240 --
Operating Expense 538,306 229,930 1.2M 933,478 1.2M --
Operating Income -543,434 -275,456 -1.2M -1.0M -611,310 --
EBIT -535,481 -243,781 -1.2M -1.0M -608,060 --
Interest Expense 71,864 104,760 58,659 62,421 70,576 --
Interest Expense Non Operating 71,864 104,760 58,659 62,421 70,576 --
Interest Income 7,953 6,113 1,925 1,219 3,250 --
Interest Income Non Operating 7,953 6,113 1,925 1,219 3,250 --
Net Interest Income -63,911 -98,647 -56,734 -61,202 -67,326 --
Other Income Expense -- 25,562 -705.00 -1,050 -5,803 -12,327
Other Non Operating Income Expenses -- 20,997 -- -- -- --
Gain On Sale Of Security -- 4,565 -705.00 -1,050 -5,803 -12,327
Pretax Income -607,345 -348,541 -1.2M -1.1M -678,636 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -607,345 -348,541 -1.2M -1.1M -605,813 --
Net Income From Continuing Operation Net Minority Interest -607,345 -348,541 -1.2M 227,321 -678,636 --
Net Income Including Noncontrolling Interests -607,345 -348,541 -1.2M -1.1M -605,813 --
Minority Interests 0.00 0.00 0.00 0.00 0.00 --
Net Income Common Stockholders -607,345 -348,541 -1.2M -1.1M -605,813 --
Net Income -607,345 -348,541 -1.2M -1.1M -605,813 --
EBITDA -499,261 -197,456 -1.1M -956,946 -561,659 --
Normalized EBITDA -499,261 -202,021 -1.1M -955,896 -561,659 --
Reconciled Depreciation 36,220 46,325 47,852 63,568 46,401 --
Basic EPS 0.00 0.00 -0.01 -- -0.01 0.07
Diluted EPS 0.00 0.00 -0.01 -- -0.01 0.06
Basic Average Shares 167.3M 163.0M 150.1M -- 137.5M 132.4M
Diluted Average Shares 167.3M 180.5M 150.1M -- 137.5M 158.0M
Total Unusual Items -- 4,565 -705.00 -1,050 -5,803 -12,327
Total Unusual Items Excluding Goodwill -- 4,565 -705.00 -1,050 -5,803 -12,327
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -607,345 -353,106 -1.2M 228,371 -678,636 --
Diluted NI Availto Com Stockholders -607,345 -348,541 -1.2M -1.1M -605,813 --
Net Income Continuous Operations -607,345 -348,541 -1.2M 227,321 -678,636 --
Net Income Discontinuous Operations 0.00 0.00 0.00 -1.3M 72,823 --
Net Non Operating Interest Income Expense -63,911 -98,647 -56,734 -61,202 -67,326 --
Other Gand A 378,668 139,703 942,486 325,957 986,824 --
Reconciled Cost Of Revenue 13,627 73,523 370,066 213,063 723,944 --
Total Expenses 551,933 303,453 1.6M 1.1M 1.9M --
Total Operating Income As Reported -543,434 -275,456 -1.2M -1.0M -611,310 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 939,062 1.6M 493,584 358,813 544,377 --
Cash Cash Equivalents And Short Term Investments 939,062 1.6M 493,584 358,813 544,377 --
Accounts Receivable 131,154 79,970 134,534 13,692 343,520 --
Receivables 131,154 139,083 203,981 88,084 786,862 --
Inventory 338,997 334,550 157,588 376,034 688,372 --
Prepaid Assets 262,420 300,147 440,043 -- -- --
Other Current Assets -- -- -- 205,928 192,823 166,943
Current Assets 1.7M 2.4M 1.3M 1.0M 2.2M --
Gross PPE -- 1.6M 1.7M 1.6M 1.6M 1.6M
Accumulated Depreciation -- -792,382 -753,591 -718,991 -677,913 -637,508
Net PPE 500,919 854,520 902,171 929,262 965,850 --
Goodwill And Other Intangible Assets 568,020 569,943 558,515 536,055 727,088 --
Other Intangible Assets -- 569,943 558,515 536,055 727,088 729,618
Total Non Current Assets 1.1M 1.4M 1.5M 1.5M 1.7M --
Total Assets 2.7M 3.8M 2.8M 2.5M 3.9M --
Current Debt 621,546 422,604 370,702 344,224 332,526 --
Current Debt And Capital Lease Obligation 621,546 543,676 489,976 461,726 448,283 --
Accounts Payable -- 1.0M 959,341 1.2M 699,545 510,951
Payables -- 1.4M 1.8M 1.8M 2.3M 1.8M
Payables And Accrued Expenses 1.2M 1.4M 1.8M 1.8M 2.3M --
Current Deferred Revenue -- -- -- 0.00 0.00 594,695
Other Current Liabilities -- -- -- 120,000 -- --
Current Liabilities 1.9M 2.0M 2.3M 2.4M 2.8M --
Long Term Debt 1.7M 1.4M 864,483 958,238 1.0M --
Long Term Debt And Capital Lease Obligation 1.7M 2.1M 1.6M 1.7M 1.8M --
Long Term Capital Lease Obligation -- 693,768 724,719 755,210 785,248 814,840
Total Non Current Liabilities Net Minority Interest 1.7M 2.1M 1.6M 1.7M 1.8M --
Total Liabilities Net Minority Interest 3.5M 4.0M 3.9M 4.1M 4.6M --
Common Stock 27.2M 27.1M 26.0M 24.4M 24.4M --
Capital Stock 27.2M 27.1M 26.0M 24.4M 24.4M --
Additional Paid In Capital 8.5M 8.7M 8.5M 8.3M 8.2M --
Retained Earnings -36.6M -36.0M -35.6M -34.4M -33.3M --
Common Stock Equity -793,369 -234,987 -1.1M -1.6M -688,646 --
Stockholders Equity -793,369 -234,987 -1.1M -1.6M -688,646 --
Total Equity Gross Minority Interest -793,369 -234,987 -1.1M -1.6M -688,646 --
Minority Interest -- 0.00 0.00 0.00 0.00 0.00
Total Capitalization 882,450 1.1M -269,536 -670,999 360,162 --
Net Tangible Assets -1.4M -804,930 -1.7M -2.2M -1.4M --
Tangible Book Value -1.4M -804,930 -1.7M -2.2M -1.4M --
Working Capital -186,489 402,887 -1.0M -1.4M -547,528 --
Invested Capital 1.5M 1.6M 101,166 -326,775 692,688 --
Total Debt 2.3M 2.6M 2.1M 2.2M 2.3M --
Net Debt 1.4M 178,188 741,601 943,649 836,957 --
Share Issued 167.3M 165.9M 154.8M 137.8M 137.5M --
Ordinary Shares Number 167.3M 165.9M 154.8M 137.8M 137.5M --
Assets Held For Sale Current -- -- -- 0.00 0.00 0.00
Capital Lease Obligations -- 814,840 843,993 872,712 901,005 928,878
Current Capital Lease Obligation -- 121,072 119,274 117,502 115,757 114,038
Current Deferred Liabilities -- -- -- 0.00 0.00 594,695
Dueto Related Parties Current -- -- -- 0.00 8,066 8,066
Finished Goods -- 421,587 35,587 447,678 355,299 292,269
Inventories Adjustments Allowances -- -170,430 -171,514 -203,685 -48,695 -48,695
Liabilities Heldfor Sale Non Current -- -- -- 0.00 0.00 0.00
Line Of Credit -- 11,734 14,368 0.00 0.00 0.00
Machinery Furniture Equipment -- 118,508 118,508 121,817 117,327 112,335
Non Current Deferred Liabilities -- -- -- 0.00 0.00 0.00
Non Current Deferred Revenue -- -- -- 0.00 0.00 0.00
Other Current Borrowings -- 410,870 356,334 344,224 332,526 321,225
Other Equity Interest 14,505 14,505 14,505 65,767 65,767 --
Other Payable -- 402,533 851,382 642,126 1.6M 1.3M
Other Properties -- 1.5M 1.5M 1.5M 1.5M 1.5M
Other Receivables -- 59,113 69,447 74,392 443,342 143,848
Raw Materials -- 35,583 293,515 129,272 381,214 483,479
Work In Process -- 47,810 0.00 2,769 554.00 599.00
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -698,216 -772,903 -1.1M -419,877 -538,125 --
Cash Flow From Continuing Operating Activities -698,216 -772,903 -1.1M 5.3M -538,125 --
Depreciation And Amortization 36,220 46,325 47,852 63,568 46,401 --
Depreciation Amortization Depletion 36,220 46,325 47,852 63,568 46,401 --
Stock Based Compensation 23,963 -238,729 144,563 141,956 140,168 --
Change In Working Capital -149,151 -345,323 -134,714 -4.8M -109,659 --
Change In Receivables 7,929 64,898 -115,897 375,955 -25,605 --
Change In Inventory -4,447 -176,962 218,446 312,338 39,280 --
Change In Payables And Accrued Expense -190,360 -373,155 -3,148 -475,374 497,241 --
Change In Other Working Capital -- -- -- -5.0M -594,695 -298,531
Change In Other Current Assets -- -- -- -13,105 -25,880 67,835
Other Non Cash Items -266,819 82,666 57,303 14.4M -9,222 --
Capital Expenditure -5,612 -49,661 -44,832 -41,229 -8,459 --
Purchase Of PPE 0.00 -- -13,755 -4,490 -4,993 -10,194
Net PPE Purchase And Sale 60,000 8,860 -13,755 -4,490 -4,993 --
Sale Of Business 0.00 0.00 -- 72,823 0.00 9.6M
Investing Cash Flow 54,388 -40,801 -44,832 31,594 -8,459 --
Cash Flow From Continuing Investing Activities 54,388 -40,801 -44,832 31,594 -8,459 --
Issuance Of Debt 0.00 1.0M -- 0.00 0.00 0.00
Repayment Of Debt -21,353 -113,153 -154,719 -154,293 -153,873 --
Net Issuance Payments Of Debt -21,353 886,847 -154,719 -154,293 -153,873 --
Issuance Of Capital Stock 0.00 1.1M 1.5M 0.00 0.00 --
Net Common Stock Issuance 0.00 1.1M 1.5M 0.00 0.00 --
Financing Cash Flow -30,095 1.9M 1.3M 202,719 81,033 --
Cash Flow From Continuing Financing Activities -30,095 1.9M 1.3M 202,719 81,033 --
Changes In Cash -673,923 1.1M 134,771 -1.3M -465,551 --
Beginning Cash Position 1.6M 493,584 358,813 544,377 1.0M --
End Cash Position 939,062 1.6M 493,584 358,813 544,377 --
Free Cash Flow -703,828 -822,564 -1.1M -461,106 -546,584 --
Amortization Cash Flow 7,535 7,534 8,617 22,490 5,996 --
Amortization Of Intangibles 7,535 7,534 8,617 22,490 5,996 --
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00 --
Cash From Discontinued Financing Activities 0.00 0.00 0.00 0.00 0.00 --
Cash From Discontinued Investing Activities 0.00 0.00 0.00 0.00 0.00 --
Cash From Discontinued Operating Activities 0.00 0.00 0.00 -9.3M 0.00 --
Change In Prepaid Assets 37,727 139,896 -234,115 -- -- 67,835
Common Stock Issuance 0.00 1.1M 1.5M 0.00 0.00 --
Depreciation 28,685 38,791 39,235 41,078 40,405 --
Gain Loss On Investment Securities 0.00 -- -1,803 -- -- --
Gain Loss On Sale Of PPE 264,916 30,699 1,611 205,282 0.00 --
Interest Paid Cff -36,254 -12,515 -12,948 -13,374 -13,794 --
Long Term Debt Issuance -- -- -- 0.00 0.00 0.00
Long Term Debt Payments -21,353 -113,153 -154,719 -6.2M -153,873 --
Net Business Purchase And Sale 0.00 0.00 -- 72,823 0.00 9.6M
Net Income From Continuing Operations -607,345 -348,541 -1.2M -1.1M -605,813 --
Net Intangibles Purchase And Sale -5,612 -49,661 -31,077 -36,739 -3,466 --
Net Long Term Debt Issuance 978,647 -113,153 -154,719 -6.2M -153,873 --
Net Other Financing Charges -- -27,512 -- -- -- --
Net Other Investing Changes -- -- -- 0.00 -- -490,643
Net Short Term Debt Issuance -- 1.0M -- -- 0.00 0.00
Operating Gains Losses 264,916 30,699 -192.00 205,282 -- --
Other Cash Adjustment Outside Changein Cash 0.00 0.00 0.00 749,248 0.00 --
Proceeds From Stock Option Exercised -- -- -- 250,386 248,700 --
Purchase Of Intangibles -5,612 -49,661 -31,077 -36,739 -3,466 --
Sale Of PPE -- 8,860 -- -- -- --
Short Term Debt Issuance -- 1.0M -- -- 0.00 0.00
Short Term Debt Payments -- -- -- -- 0.00 --
NEWS
Loading news...
TRENDING
Loading...